Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients?

Puzzoni M.;Ziranu P.;Lai E.;Mariani S.;Pretta A.;MUSIO, FRANCESCA;PERSANO, MARA;Scartozzi M.
2020-01-01
2020
2019
Inglese
FUTURE ONCOLOGY
16
2
4337
4339
3
WOS:000508439200001
2-s2.0-85076871972
31793396
http://www.futuremedicine.com/loi/fon
https://www.futuremedicine.com/doi/10.2217/fon-2019-0624?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=www.ncbi.nlm.nih.gov&
Esperti anonimi
internazionale
scientifica
MONOCLONAL-ANTIBODIES; EGFR BLOCKADE; RESISTANCE; EVOLUTION
no
Puzzoni, M.; Ziranu, P.; Demurtas, L.; Lai, E.; Mariani, S.; Liscia, N.; Soro, P.; Pretta, A.; Impera, V.; Camera, S.; Musio, Francesca; Persano, Mara ...espandi
1.1 Articolo in rivista
info:eu-repo/semantics/article
1 Contributo su Rivista::1.1 Articolo in rivista
262
16
reserved
Files in This Item:
File Size Format  
FutureOncol2019.pdf

Solo gestori archivio

Type: versione editoriale
Size 1.24 MB
Format Adobe PDF
& nbsp; View / Open   Request a copy
1.24 MB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie